期刊文献+

224例医院内尿路感染病原菌分布和耐药分析 被引量:6

Pathogenic bacterium distribution and antibiotics resistance analysis of nosocomial urinary tract infection
下载PDF
导出
摘要 目的了解医院内尿路感染的致病因素、病原菌分布和耐药性。方法选取2004年6月至2006年6月医院内尿路感染224例进行分析。结果医院内尿路感染占医院感染18.3%。224例中,留置导尿管201例,占89.7%;发生感染时间:5d内为15.9%;14d内为91.5%;20d内为100%。培养出革兰氏阴性杆菌56.1%,真菌29.3%,革兰氏阳性球菌14.6%。其中大肠埃希菌26.8%,白假丝酵母22.0%,阴沟肠杆菌12.7%。药敏试验结果表明:对大多数革兰氏阴性杆菌有效抗菌素依次是亚胺培南、哌啦西林/舒巴坦、阿米卡星;对大多数革兰氏阳性球菌有效抗菌素依次为呋喃妥因、阿米卡星、万古霉素。结论留置导尿管时间长短是医院内尿路感染主要致病因素;病原菌以革兰氏阴性杆菌为主,而真菌感染有明显上升趋势;致病菌存在较高耐药性。 Objective To understand the disease causes of nosocomial infection, pathogenic bacterium distribution and its antibiotics resistance. Methods 224 cases of urinary tract infection patients from June 2004 to June 2006 were analyzed. Results The nosocomial urinary infection accounted for 18.3% of the hospital infection. Of 224 cases , 201 cases were caused by detaining leading urine tube, covering 89.7% . The onset time of infection were within 5 days, 15.9% ; 14 days , 91.5% ;20 days , 100%. Gram-negative becillus, fungi, gram-pnsitive bacillus, oscherichia coli, candida albicans, guam-positive coccus accounted for 56. 1% ,29.3% ,14.6% ,26.8% ,22.0% ,12.7%, respectively. Antibiotics sensitive experimental results showed : to most gram-negative becillus, the effective antibiotics were lmipenem, Piperacillin/Sulbactam, Amikacin consecutively; to most guam-positive coccus, Furadantin, Amikacin and Vancomycin consecutively. Conclusion The prolonged time of detaining urine tube is the major risk factor of nosecomial urinary infection. The pathogenic bacterium are mainly gram-negative beeillus, with fungi a rising pathogenic bacteria. All these pathogenic bacteria show high antibiotics resistance.
作者 李家生
出处 《内科》 2007年第1期21-23,共3页 Internal Medicine
关键词 医院内尿路感染 病原菌 耐药性 Nosocomial infection pathogenic bacterium Antibicties resistance
  • 相关文献

参考文献4

二级参考文献11

  • 1卫生部医政司医院感染监控协调小组.全国医院感染监控系统监测报告[J].中华流行病学杂志,1991,12(5):21-21.
  • 2卫生部医政司医院内感染监控协调小组,中华流行病学杂志,1991年,12卷,特5期,21页
  • 3Yu WL,Chuang YC,Jones RN.A pragmatic approach to identify extended-spectrum beta-lactamase-producing klebsiella pneumoniae in Taiwan:in vitro activity of newer and established antimicrobial agents.Diagn Microbiol Infect Dis,2004,48(4):277-282
  • 4Gupta A,Della-Latta P,Todd B,et al.Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails.Infect Control Hosp Epidemiol,2004,25(3):210-215
  • 5Sturenburg E,Mack D.Extended-spectrum beta-lactamases:implications for the clinical microbiology laboratory,therapy,and infection control.J Infect,2003,47(4):273-295
  • 6Lavigne JP,Bonnet R,Michaux-Charachon S,et al.Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.J Antimicrob Chemother,2004,53(4):616-619
  • 7Pfaller MA,Jones RN.Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme,Europe 1997-2000.Int J Antimicrob Agents,2002,19(5):383-
  • 8涂启茂.医院感染管理工作中6个不相适应的问题[J].中华医院感染学杂志,2000,10(1):58-59. 被引量:16
  • 9周志慧,李兰娟,俞云松,马亦林.阴沟肠杆菌耐药及ampC基因表达状况研究[J].中华传染病杂志,2002,20(6):337-340. 被引量:15
  • 10汪复,朱德妹,吴湜,胡付品,张婴元.革兰阴性杆菌耐药性变迁[J].中国抗感染化疗杂志,2003,3(2):65-70. 被引量:83

共引文献455

同被引文献29

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部